» Articles » PMID: 35776683

Mechanisms of COVID-19 Pathogenesis in Diabetes

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in 190 countries. Comorbidities, particularly cardiovascular disease, diabetes, and hypertension, increase the risk of infection and poor outcomes. SARS-CoV-2 enters host cells through the angiotensin-converting enzyme-2 receptor, generating inflammation and cytokine storm, often resulting in multiorgan failure. The mechanisms and effects of COVID-19 on patients with high-risk diabetes are not yet completely understood. In this review, we discuss the variety of coronaviruses, structure of SARS-CoV-2, mutations in SARS-CoV-2 spike proteins, receptors associated with viral host entry, and disease progression. Furthermore, we focus on possible mechanisms of SARS-CoV-2 in diabetes, leading to inflammation and heart failure. Finally, we discuss existing therapeutic approaches, unanswered questions, and future directions.

Citing Articles

Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus.

Li J, Zhang Y, Wu R, Ma G, Sheng L, Feng Y Risk Manag Healthc Policy. 2024; 17:2535-2545.

PMID: 39479559 PMC: 11523978. DOI: 10.2147/RMHP.S490281.


Chemerin Levels in COVID-19 Are More Affected by Underlying Diseases than by the Virus Infection Itself.

Pavel V, Amend P, Schmidtner N, Utrata A, Birner C, Schmid S Biomedicines. 2024; 12(9).

PMID: 39335612 PMC: 11430512. DOI: 10.3390/biomedicines12092099.


Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C).

Wong R, Hall M, Wiggen T, Johnson S, Huling J, Turner L Diabetes Care. 2024; 47(10):1846-1854.

PMID: 39207804 PMC: 11417274. DOI: 10.2337/dc24-1003.


Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients.

Li D, Fang Q, Chen Z, Tang J, Tang H, Cai N Front Pharmacol. 2024; 15:1381830.

PMID: 39144619 PMC: 11321974. DOI: 10.3389/fphar.2024.1381830.


Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.

Erlandson K, Geng L, Selvaggi C, Thaweethai T, Chen P, Erdmann N Ann Intern Med. 2024; 177(9):1209-1221.

PMID: 39133923 PMC: 11408082. DOI: 10.7326/M24-0737.


References
1.
Cao X . COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020; 20(5):269-270. PMC: 7143200. DOI: 10.1038/s41577-020-0308-3. View

2.
Redondo N, Zaldivar-Lopez S, Garrido J, Montoya M . SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns. Front Immunol. 2021; 12:708264. PMC: 8293742. DOI: 10.3389/fimmu.2021.708264. View

3.
Yang Z, Huang Y, Ganesh L, Leung K, Kong W, Schwartz O . pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol. 2004; 78(11):5642-50. PMC: 415834. DOI: 10.1128/JVI.78.11.5642-5650.2004. View

4.
Sacar Demirci M, Adan A . Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ. 2020; 8:e9369. PMC: 7278893. DOI: 10.7717/peerj.9369. View

5.
Xu B, Fan D, Zhao Y, Li J, Wang Z, Wang J . Three-Dimensional Culture Promotes the Differentiation of Human Dental Pulp Mesenchymal Stem Cells Into Insulin-Producing Cells for Improving the Diabetes Therapy. Front Pharmacol. 2020; 10:1576. PMC: 6993085. DOI: 10.3389/fphar.2019.01576. View